1. Home
  2. FMS

as of 03-12-2026 3:39pm EST

$22.85
+$0.09
+0.42%
Stocks Health Care Misc Health and Biotechnology Services Nasdaq

Fresenius Medical Care is the largest dialysis company in the world, treating about 300,000 patients from nearly 3,700 clinics worldwide as of December 2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.

Founded: 1996 Country:
Germany
Germany
Employees: N/A City: N/A
Market Cap: 14.2B IPO Year: N/A
Target Price: $30.00 AVG Volume (30 days): 572.5K
Analyst Decision: Sell Number of Analysts: 2
Dividend Yield:
2.51%
Dividend Payout Frequency: N/A
EPS: N/A EPS Growth: N/A
52 Week Low/High: $20.95 - $30.46 Next Earning Date: N/A
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): 1.41% Revenue Growth (next year): 4.11%
P/E Ratio: 15.62 Index: N/A
Free Cash Flow: N/A FCF Growth: +4.67%

Latest Fresenius Medical Care AG News

FMS Breaking Stock News: Dive into FMS Ticker-Specific Updates for Smart Investing

All FMS News

Share on Social Networks: